ARCUTIS BIOTHERAPEUTICS, INC. — Revenue by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/188461c8-5d76-4516-8b62-f9d743d23bce/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $372.1M | 2025-01-01 – 2025-12-31 | evidence 0001787306-26-000018 |
| FY 2024 | $166.5M | 2024-01-01 – 2024-12-31 | evidence 0001787306-25-000029 |
| FY 2023 | $29.2M | 2023-01-01 – 2023-12-31 | evidence 0001787306-25-000029 |
| FY 2022 | $3.7M | 2022-01-01 – 2022-12-31 | evidence 0001787306-23-000023 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0001787306-23-000023 |
| FY 2020 | $0 | 2020-01-01 – 2020-12-31 | evidence 0001787306-23-000023 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
ARCUTIS BIOTHERAPEUTICS, INC. — all facts · Net Income · Operating Income